May 22, 2024
NFP announced its acquisition of HELPGB

KBI Biopharma appoints Jean-Baptiste Agnus as Chief Business Officer

Jean-Baptiste-Agnus, Chief Business Officer, KBI Biopharma Image taken from KBI Biopharma website

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), yesterday announced the appointment of Jean-Baptiste (JB) Agnus as Chief Business Officer, solidifying KBI’s Executive Team.

JB brings more than two decades of experience across various sectors of the biopharmaceutical industry with expertise in commercial development in biologics, small molecule APIs, antibody-drug conjugates (ADCs), and the latest advancements in cell and gene therapies. With a proven track record of implementing winning sales strategies and cultivating high-performing teams, JB will lead KBI’s global business development initiatives, driving the company towards continued growth and sustained success. This pivotal role is focused on building and maintaining long-lasting partnerships with KBI’s current and future customers around the globe. JB’s commitment to fostering relationships with external partners and internal team members alike is a value that aligns well with KBI’s collaborative culture.

J.D. Mowery, President & CEO of KBI Biopharma
Image taken from KBI Biopharma website

“Our dedication to growth and commitment to our partners, their patients, and our people guide every decision at KBI Biopharma,” remarked J.D. Mowery, President & CEO of KBI Biopharma. “JB’s appointment underscores this dedication, perfectly aligning with our team’s mission to deliver innovative, top-tier solutions tailored to our customers’ evolving needs. His servant leadership philosophy will further fortify our team, propelling KBI to new heights.”

“KBI Biopharma is an innovator in the testing, development, manufacturing, and commercialization of life-changing therapies,” said JB Agnus, Chief Business Officer of KBI Biopharma. “Strong partnerships are at the core of KBI’s success. I am excited to join the passionate team at KBI, who are committed to ensuring transformative treatments reach those in need by nurturing meaningful customer relationships.”

Logo taken from KBI Biopharma website

Before joining KBI, JB held leadership roles in business development at AGC Biologics, Ajinomoto Bio-Pharma Services, Novasep, and Isochem. He holds a Master of Science in Chemical Engineering from Centrale Marseille.


Interested to know about other Biopharma companies? Then please read:

Hansa Biopharma welcomes Dr. Hitto Kaufmann as Chief Scientific Officer

Kindeva Drug Delivery Appoints Jennifer Riter as New VP of Analytical Services

InterAx Biotech Appoints Mark Levick, MD, Ph.D. As New DOB

(Visited 14 times, 1 visits today)



Comments are closed.

Social Media

Most Popular

LRMF missile
Aerojet Rocketdyne joins Lockheed Martin to develop LRMF missile
Maria Jackson
Tahini located in the vibrant One Central.
GRIT Hospitality launches Tahini in Dubai
3D Systems and SWANY partnership to promote large-format pellet extrusion 3D printing

Related Posts